Skip to content
  • What does normal mean here? Why a single measurement says nothing without a comparison group

    What does normal mean here? Why a single measurement says nothing without a comparison group

    Imagine someone tells you: «The child is 108 centimetres tall.» Is that a lot? A little? Cause for concern? The question cannot be answered. Not because the number is imprecise — it is perfectly exact — but because the decisive part is missing: a comparison. Only the follow-up question «how old is the child?» turns…

    October 10, 2026
  • Making trauma measurable? What brain function analysis can do in PTSD — and what it cannot

    Making trauma measurable? What brain function analysis can do in PTSD — and what it cannot

    Why PTSD is so hard to pin down Of the four themes the Biomarker Workshop circles around in December — ADHD, autism, PTSD and sensitivity — post-traumatic stress disorder is the most awkward when it comes to measurement. With ADHD and autism we are looking at development that takes a different course. With PTSD we…

    October 10, 2026
  • Biomarker Workshop 2026: Sensitivity and Stress in ADHD, Autism and PTSD

    Biomarker Workshop 2026: Sensitivity and Stress in ADHD, Autism and PTSD

    ADHD, autism and PTSD are listed as separate diagnoses. Clinically and neurobiologically, however, they overlap considerably. The 2026 workshop examines the proposition that two dimensions lie beneath these diagnoses: sensitivity — how much a nervous system takes in from its environment and amplifies — and stress — what that intake costs the system. All three…

    October 10, 2026
  • ADHD in the Spectrum of Neurodiversity. New Paths: Understand First, Then Treat

    ADHD in the Spectrum of Neurodiversity. New Paths: Understand First, Then Treat

    Same diagnosis, very different brains: on 8 October 2026, 16:00–18:00, Andreas Müller will show at the Logosynthese Institut Schweiz in Bad Ragaz how brain function analysis makes ADHD understandable within the spectrum of neurodiversity, and how this leads to personalised treatment. Talk by Dr. phil. Andreas MüllerThursday, 8 October 2026, 16:00–18:00Logosynthese Institut Schweiz, Bahnhofstrasse 38,…

    September 11, 2026
  • Workshop in the Canton of Ticino

    Workshop in the Canton of Ticino

    [2026/09/10], 11:15 – Understanding the brain before intervening: a scientific and automated approach to the analysis of EEG, ERP and microstates Speakers: Dr. phil. Andreas Müller, psychologist, specialist in psychotherapy FSP, head of BrainARC-Ostschweiz and HBImed. For many years he has worked in neuroscience, quantitative EEG (qEEG) assessment, and evidence-based diagnosis and treatment. Fabian Bazzana,…

    September 11, 2026
  • Why memory is a poor gauge of progress — and what regular measurement changes

    Why memory is a poor gauge of progress — and what regular measurement changes

    Almost every session begins with the same question: “So, how have you been since last time?” It is a good question. It is also the only one most treatments have for finding out whether they work. And it has a design flaw worth knowing about: it asks a person to summarise two, four or six…

    September 5, 2026
  • How do you know a therapy is working?

    Why memory is a poor gauge of progress — and what regular measurement changes 1. The question at the start of the session At the start of the session there is almost always the same question: “So, how have things been since last time?” It is a good question. It is also the only one…

    September 5, 2026
  • The Dimension Beneath the Diagnoses

    Sensitivity as the common denominator of ADHD, autism and PTSD — an overview of the concept, the evidence and the diagnostic consequences 1. Why the question arises Anyone who spends enough time assessing people with ADHD, with an autism spectrum disorder and with post-traumatic stress disorder makes an observation that appears in no diagnostic manual:…

    September 5, 2026
  • HBImed apps explained live: online session on 5 October 2026

    HBImed apps explained live: online session on 5 October 2026

    Note: This session has already taken place. Monday, 5 October 2026, 6:00–7:00 p.m. (CEST) – online via Zoom, about one hour. The Brain and Trauma Foundation Graubünden presents the two HBImed apps: the questionnaire app and the tracker app. Participation is free of charge. Diagnostics and follow-up depend on data that is collected in a…

    August 21, 2026
  • Autism assessment: the lost year

    Autism assessment: the lost year

    Why autism assessment is reaching its limits — and what measurable brain signals can contribute Parents notice something. The child is three, perhaps four years old, and something is unfolding differently than with the siblings or the other children at playgroup. They speak to their paediatrician, they receive a referral — and then they wait.…

    August 17, 2026
  • High sensitivity and vigilance: the myth of the permanent alarm

    High sensitivity and vigilance: the myth of the permanent alarm

    A new bachelor’s thesis at the ZHAW is the first to test whether high sensitivity shows up in the event-related potentials of the EEG. The result sits poorly with the widespread image of a permanently over-aroused nervous system – and puts a different quantity at the centre instead: vigilance. The picture of a permanent alarm…

    August 17, 2026
  • When ADHD and depression coincide: what the EEG reveals

    When ADHD and depression coincide: what the EEG reveals

    A new bachelor’s thesis at ZHAW investigates whether EEG biomarkers can help detect comorbid depression more reliably in adults with ADHD. The results are encouraging – and at the same time mark the limits of purely neurophysiological diagnostics.

    August 5, 2026
  • Biomarker Workshop 2025: ADHD-Autism-Anxiety-Hypersensitivity

    Biomarker Workshop 2025: ADHD-Autism-Anxiety-Hypersensitivity

    Programme – Biomarker Workshop 2025 9:00       Welcome: Andreas Müller 9:15     A. Müller: “From Vision to Reality: Practical Biomarker Applications in ADHD, Autism, Anxiety and Sensory Sensitivity” Slides 10:00:    Attwood/Garnet: Beyond the Stereotypes: Biomarkers for the Hidden Presentations of Autism, ADHD, and Anxiety – Insights from 80 Years of Clinical Practice” Handout See also…

    July 23, 2026
  • HBImed Therapy Tracking: making the course of therapy visible

    HBImed Therapy Tracking: making the course of therapy visible

    A single appointment only ever shows one moment in time. How a patient is doing between sessions often stays invisible – and decisions then rest on memory rather than data. This is exactly where HBImed Therapy Tracking comes in: the tool accompanies patients between appointments and turns individual snapshots into a picture of their development. Developed…

    July 23, 2026
  • The HBImed Questionnaire App: 50 clinical questionnaires, digital and automatically scored

    The HBImed Questionnaire App: 50 clinical questionnaires, digital and automatically scored

    Clinical questionnaires are part of everyday life in many practices – yet sending them out, collecting them and scoring them on paper costs time and is prone to error. The HBImed Questionnaire App maps this entire workflow digitally: from inviting the patient to the finished, scored result. It was developed by the GTSG (Brain and…

    July 23, 2026
  • Differentiating the use of methylphenidate and amphetamines in ADHD

    Differentiating the use of methylphenidate and amphetamines in ADHD

    A scientific analysis with particular reference to EEG, ERP and microstate biomarkers Summary Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders, affecting around 5% of children and 2.5% of adults worldwide. Psychostimulants, in particular methylphenidate (MPH) and amphetamines (AMP), represent the first-line pharmacological treatment. Although both classes of substances increase…

    January 26, 2026
  • ADHD, autism spectrum disorder and sleep problems: a systematic review of comorbidities, neurobiological mechanisms and evidence-based treatment approaches

    ADHD, autism spectrum disorder and sleep problems: a systematic review of comorbidities, neurobiological mechanisms and evidence-based treatment approaches

    Abstract Attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), anxiety disorders and sleep disorders show high rates of comorbidity with complex bidirectional relationships. This systematic review analyses current research findings on prevalence, neurobiological mechanisms and evidence-based treatment approaches. More than 80% of people with ASD experience sleep problems, while 28% additionally meet criteria for ADHD. Anxiety…

    January 13, 2026
  • Why the EEG interpretation course is your next step.

    Why the EEG interpretation course is your next step.

    The Biomarker Workshop 2025 showed what is possible. 250 participants experienced how international experts—led by Tony Attwood and Michelle Garnett—outlined the future of psychiatric diagnostics. But between knowing what is possible and applying it on a daily basis lies a crucial step: practical competence. This is exactly where the EEG interpretation course comes in. The…

    January 3, 2026
  • Evolutionary archetypes of neurodiversity

    Evolutionary archetypes of neurodiversity

    ADHD – Autism – Anxiety – Hypersensitivity – PDA Brain and Trauma Foundation Grison (GTSG) Supplementary material for the Biomarker Workshop 2025 | 11 December 2025, Zurich Introduction: from pathology to an evolutionary perspective Modern neuroscience is beginning to understand that many conditions classified as “disorders” may have evolutionary origins. As Yuval Noah Harari describes…

    December 2, 2025
  • Therapy and support in AuDHD – the neurodiversity approach

    Therapy and support in AuDHD – the neurodiversity approach

    Part 5 of the article series on the Biomarker Workshop 2025 The treatment of people with autism and/or ADHD has changed fundamentally in recent years. Away from fighting symptoms, towards a holistic approach that understands neurodiversity as a natural variation of human neurology. The new paradigm: acceptance instead of normalisation Attwood and Garnett describe a…

    November 28, 2025
←Previous Page
1 2 3 4 … 8
Next Page→

Kontakt

Gehirn- und Traumastiftung Graubünden
Schulstrasse 1
CH-7302 Landquart

Telefon: +41 81 322 28 28
E-Mail: info@gtsg.ch

Newsletter

Bleiben Sie informiert über unsere Workshops, Forschung und Neuigkeiten.

Zum Newsletter

Rechtliches

Impressum
Datenschutz · Privacy
Kontaktformular
Jahresberichte

Contact

Brain and Trauma Foundation Grison
Schulstrasse 1
CH-7302 Landquart, Switzerland

Phone: +41 81 322 28 28
Email: info@gtsg.ch

Newsletter

Stay informed about our workshops, research and news.

Subscribe

Legal

Imprint
Privacy Policy · Datenschutz (DE)
Contact form
Annual reports


  • LinkedIn
  • Facebook
Newsletter – Jetzt anmelden